# Spire Inc: filings

SR · NYSE · CIK 1126956 · [Utilities](/sectors/utilities.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/sr.md) · [Financials](/companies/sr/financials.md) · [Filings](/companies/sr/filings.md) · [Insiders](/companies/sr/insiders.md)

## Reports and events: 359 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 466, 8-K 254, 10-Q 54, 11-K 44, SC 13G/A 44, 3 25, UPLOAD 23, CORRESP 18, DEF 14A 18, 10-K 17, DEFA14A 17, 4/A 15, 424B3 14, 8-K/A 13, S-3ASR 12, S-8 12, FWP 11, 424B2 10, 424B5 9, ARS 9, SC 13G 6, S-8 POS 5, 15-15D 4, 3/A 4, SCHEDULE 13G/A 4, 10-Q/A 2, 11-K/A 2, 305B2 2, 8-A12B 2, CERT 2, CT ORDER 2, NT 11-K 2, POSASR 2, SCHEDULE 13G 2, 10-K/A 1, 25-NSE 1, AW 1, EFFECT 1, POS AM 1, PRE 14A 1, RW 1, S-3 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-13 | 20:32 ET | [8-K](/filings/0001193125-26-420501.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-420501 |
| 2026-10-08 | 20:34 ET | [8-K](/filings/0001193125-26-417983.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-417983 |
| 2026-09-01 | 20:31 ET | [8-K](/filings/0001193125-26-378491.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-378491 |
| 2026-08-05 | 15:59 ET | [10-Q](/filings/0001193125-26-334335.md) | Quarterly report, period 2026-06-30 | 0001193125-26-334335 |
| 2026-08-05 | 11:06 ET | [8-K](/filings/0001193125-26-333825.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-333825 |
| 2026-07-08 | 20:32 ET | [8-K](/filings/0001193125-26-298586.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-298586 |
| 2026-06-30 | 20:33 ET | [8-K](/filings/0001193125-26-290674.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-290674 |
| 2026-05-06 | 17:32 ET | [10-Q](/filings/0001193125-26-208452.md) | Quarterly report, period 2026-03-31 | 0001193125-26-208452 |
| 2026-05-06 | 11:03 ET | [8-K](/filings/0001193125-26-207533.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-207533 |
| 2026-05-01 | 11:26 ET | [8-K](/filings/0001193125-26-199096.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-199096 |
| 2026-04-30 | 20:32 ET | [8-K](/filings/0001193125-26-197505.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-197505 |
| 2026-04-22 | 11:02 ET | [8-K](/filings/0001193125-26-168301.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-168301 |
| 2026-04-15 | 11:02 ET | [8-K](/filings/0001193125-26-155936.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-155936 |
| 2026-04-06 | 21:20 ET | [8-K/A](/filings/0001193125-26-144025.md) | 9.01 Financial statements and exhibits | 0001193125-26-144025 |
| 2026-03-31 | 20:32 ET | [8-K](/filings/0001193125-26-134715.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-134715 |
| 2026-03-30 | 11:02 ET | [8-K](/filings/0001193125-26-130379.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-130379 |
| 2026-03-16 | 20:15 ET | [8-K](/filings/0001193125-26-108363.md) | 8.01 Other events | 0001193125-26-108363 |
| 2026-02-18 | 21:18 ET | [8-K](/filings/0001193125-26-057095.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-057095 |
| 2026-02-09 | 18:11 ET | [8-K](/filings/0001193125-26-042374.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-042374 |
| 2026-02-03 | 16:36 ET | [10-Q](/filings/0001193125-26-034779.md) | Quarterly report, period 2025-12-31 | 0001193125-26-034779 |
| 2026-02-03 | 12:04 ET | [8-K](/filings/0001193125-26-034418.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-034418 |
| 2026-01-30 | 21:15 ET | [8-K](/filings/0001193125-26-031837.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-031837 |
| 2026-01-29 | 22:26 ET | [8-K](/filings/0001193125-26-029706.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-029706 |
| 2026-01-12 | 16:49 ET | [8-K](/filings/0001193125-26-010094.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-010094 |
| 2025-12-18 | 19:06 ET | [8-K](/filings/0001193125-25-324353.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-324353 |
| 2025-12-17 | 18:26 ET | [8-K](/filings/0001193125-25-322260.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-322260 |
| 2025-12-16 | 13:30 ET | [DEF 14A](/filings/0001308179-25-000657.md) | Proxy statement, period 2026-01-29 | 0001308179-25-000657 |
| 2025-12-08 | 12:30 ET | [8-K](/filings/0001193125-25-310579.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-310579 |
| 2025-11-24 | 18:28 ET | [8-K](/filings/0001193125-25-293344.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-293344 |
| 2025-11-17 | 16:43 ET | [8-K](/filings/0001193125-25-284201.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-284201 |
| 2025-11-14 | 19:24 ET | [10-K](/filings/0001193125-25-282583.md) | Annual report, period 2025-09-30 | 0001193125-25-282583 |
| 2025-11-14 | 12:06 ET | [8-K](/filings/0001193125-25-281513.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-281513 |
| 2025-10-24 | 12:01 ET | [8-K](/filings/0001193125-25-249378.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-25-249378 |
| 2025-09-22 | 12:03 ET | [8-K](/filings/0001193125-25-210056.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-210056 |
| 2025-08-05 | 15:36 ET | [10-Q](/filings/0000950170-25-102597.md) | Quarterly report, period 2025-06-30 | 0000950170-25-102597 |
| 2025-08-05 | 11:04 ET | [8-K](/filings/0000950170-25-102385.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-102385 |
| 2025-07-29 | 11:00 ET | [8-K](/filings/0001193125-25-167129.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-167129 |
| 2025-05-07 | 21:14 ET | [8-K](/filings/0001193125-25-115074.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-115074 |
| 2025-05-01 | 20:11 ET | [8-K](/filings/0000950170-25-061840.md) | 8.01 Other events | 0000950170-25-061840 |
| 2025-04-30 | 14:40 ET | [10-Q](/filings/0000950170-25-060698.md) | Quarterly report, period 2025-03-31 | 0000950170-25-060698 |
| 2025-04-30 | 11:12 ET | [8-K](/filings/0000950170-25-060569.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-060569 |
| 2025-04-29 | 20:22 ET | [8-K/A](/filings/0000950170-25-060175.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-060175 |
| 2025-04-25 | 12:30 ET | [8-K](/filings/0000950170-25-058353.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-058353 |
| 2025-04-21 | 20:14 ET | [8-K](/filings/0000950170-25-056298.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0000950170-25-056298 |
| 2025-02-05 | 15:30 ET | [10-Q](/filings/0000950170-25-014213.md) | Quarterly report, period 2024-12-31 | 0000950170-25-014213 |
| 2025-02-05 | 12:21 ET | [8-K](/filings/0000950170-25-014157.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-014157 |
| 2025-02-03 | 21:29 ET | [8-K](/filings/0000950170-25-012344.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-012344 |
| 2025-01-31 | 21:15 ET | [8-K](/filings/0000950170-25-011755.md) | 5.07 Shareholder vote results | 0000950170-25-011755 |
| 2025-01-06 | 13:29 ET | [8-K](/filings/0001437749-25-000385.md) | 5.02 Departure or appointment of officers or directors | 0001437749-25-000385 |
| 2024-12-18 | 13:30 ET | [DEF 14A](/filings/0001308179-24-000822.md) | Proxy statement, period 2025-01-30 | 0001308179-24-000822 |

Page 1 of 8. [Older](/companies/sr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.